🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to use 3D imaging to evaluate the effects of fo...
Status
Completed
Location
Penn Medicine
Start Date
2022-03-04
Trial ID
NCT05167864
This study is designed to evaluate the safety and efficacy of a single dose...
Status
Completed
Location
Clinical Testing of Beverly Hills
Start Date
2020-02-10
Trial ID
NCT04247074
Treatments Being Tested
The objective of the study is to evaluate the efficacy and safety of a sing...
Status
Completed
Location
Ablon Skin Institute and Research Center
Start Date
2020-02-10
Trial ID
NCT04249687
Treatments Being Tested
This is a phase 3, multicenter, open-label study to evaluate the safety of ...
Status
Completed
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2020-01-27
Trial ID
NCT04225260
Treatments Being Tested
The goal of this split-face clinical trial is to test the efficacy of micro...
Status
Completed
Location
K. Kay Durairaj, MD, A Medical Corp.
Start Date
2024-09-03
Trial ID
NCT06604832
Treatments Being Tested
The objective of the study is to evaluate the efficacy and safety of a sing...
Status
Completed
Location
\Ablon Skin Institute and Research Center
Start Date
2020-02-10
Trial ID
NCT04249583
Treatments Being Tested
Psoriasis is a systemic chronic relapsing immune-mediated disease which oft...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06
Trial ID
NCT06203470
Treatments Being Tested
The purpose of this study is to compare the effectiveness of three commerci...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT03048383
Ten subjects will be enrolled in the study. Each subject will have their le...
Status
Completed
Location
Lupo Center for Aesthetic and General Dermatology
Start Date
2023-05-01
Trial ID
NCT05807412
Treatments Being Tested